Impact of the Geographical FACTor on the Prostate Cancer Stage at Hormonal Therapy Initiation

NCT01729676 · clinicaltrials.gov ↗

COMPLETED

Status

315

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Degarelix or GnRH agonist

Sponsor

Ferring Pharmaceuticals